5 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $14825 | -$6M | 0.0% | -43737.5% | -$6M | — | $0 |
| 2024 | $34890 | -$8M | 0.0% | -23977.9% | -$5M | — | $0 |
| 2023 | $17065 | -$8M | 0.0% | -42440.4% | -$6M | — | $0 |
| 2022 | $950 | -$5M | 0.0% | -478784.3% | — | — | $0 |
| 2021 | $901 | -$620448 | 0.0% | -68862.2% | — | — | $0 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $2680 | -$2M | 0.0% | -66598.4% | -$2M | — | $0 |
| Dec '25 | $3555 | -$1M | 0.0% | -41159.5% | -$1M | — | $0 |
| Sep '25 | $2855 | -$2M | 0.0% | -59950.9% | -$2M | — | $0 |
| Jun '25 | $7475 | -$2M | 0.0% | -22457.5% | -$2M | — | $0 |
| Mar '25 | $940 | -$2M | 0.0% | -173463.8% | -$1M | — | $0 |
| Dec '24 | $4512 | -$2M | 0.0% | -33608.2% | -$1M | — | $0 |
| Sep '24 | $6580 | -$1M | 0.0% | -21412.9% | -$1M | — | $0 |
| Jun '24 | $7870 | -$1M | 0.0% | -16295.6% | -$1M | — | $0 |
| Mar '24 | $15928 | -$4M | 0.0% | -26105.3% | -$1M | — | $0 |
| Dec '23 | $5310 | -$1M | 0.0% | -29039.5% | -$2M | — | $0 |
| Sep '23 | $10030 | -$2M | 0.0% | -14398.7% | -$1M | — | $0 |
| Jun '23 | $1725 | -$4M | 0.0% | -148008.2% | — | — | $0 |
| Mar '23 | $0 | -$1M | — | — | — | — | $0 |
| Dec '22 | $950 | -$2M | 0.0% | -250321.8% | — | — | $0 |
| Sep '22 | $0 | -$1M | — | — | -$1M | — | $0 |
| Jun '22 | $0 | -$841998 | — | — | — | — | $0 |
| Mar '22 | $0 | -$290055 | — | — | — | — | $0 |
| Sep '21 | — | -$721 | — | — | — | — | — |
How the market has priced CDIO against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 4 years, Cardio Diagnostics Holdings, Inc.'s revenue has grown 101.4% per year. These are computed facts, not advice.
As of FY2025, Cardio Diagnostics Holdings, Inc. reported — of total debt against $0 of cash; operating income covered interest expense -438.1×.
In FY2025, gross margin was —, operating margin -43737.5%, and net margin -43832.5%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.